Synthetic Chemistry assumes a central role in crafting innovative compounds and materials with versatile applications. This scientific discipline revolves around the art of synthesizing both organic and inorganic molecules through finely tuned chemical reactions, empowering scientists to engineer substances endowed with precise properties and functionalities.
At its essence, Synthetic Chemistry is propelled by the quest to comprehend, manipulate, and leverage the intricacies of molecular structures. In the realm of pharmaceuticals, it takes center stage, with researchers employing their creativity to design and produce compounds tailored for therapeutic purposes.
Beyond pharmaceuticals, Synthetic Chemistry significantly contributes to materials science, giving rise to polymers, catalysts, and nanomaterials that impact diverse industries, from electronics to energy storage. The emergence of green and sustainable practices within synthetic chemistry emphasizes eco-friendly processes, renewable resources, and waste reduction.
As a dynamic and evolving field, Synthetic Chemistry embraces the integration of computational methods, automation, and artificial intelligence. This amalgamation of traditional techniques with modern technologies positions Synthetic Chemistry as a cornerstone in addressing scientific challenges and propelling progress across various scientific domains.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia